Ads
related to: hyperphosphatemia when to treat a patient- About This Treatment
Learn More About This
Treatment Option
- Dosing Information
View Dosing & Prescribing
Information For This Treatment
- Copay Information
Learn More About Our
Copay Savings Program
- Safety Information
Important Safety Information
And Possible Side Effects
- About This Treatment
Search results
Results From The WOW.Com Content Network
Hyperphosphatemia is an electrolyte disorder in which there is an elevated level of phosphate in the blood. [1] Most people have no symptoms while others develop calcium deposits in the soft tissue. [1] The disorder is often accompanied by low calcium blood levels, which can result in muscle spasms. [1]
Sevelamer is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals.
Phosphate nephropathy or nephrocalcinosis [1] is an adverse renal condition that arises with a formation of phosphate crystals within the kidney's tubules. This renal insufficiency is associated with the use of oral sodium phosphate (OSP) such as C.B. Fleet's Phospho soda and Salix's Visocol, for bowel cleansing prior to a colonoscopy.
When kidney function is impaired, phosphate excretion declines. Without specific treatment, hyperphosphataemia occurs almost universally, despite dietary phosphate restriction and conventional dialysis treatment. [12] [13] In patients on dialysis, hyperphosphataemia is an independent risk factor for fractures, cardiovascular disease and mortality.
- American Association of Kidney Patients* Phosphate Binders - National Kidney Foundation; Phosphate Binders - Northwest Kidney Centers - a center that provides services for people with ESRD in the Seattle area. High Phosphate - Phosphorus Control - Information for healthcare professionals on the treatment and management of hyperphosphatemia
[3] [27] Once the patient is stable, it is important to identify the underlying cause of hypernatremia as that may affect the treatment plan. [ 3 ] [ 27 ] The final step in treatment is to calculate the patients free water deficit, and to replace it at a steady rate using a combination of oral or IV fluids.
Clinical trial number NCT02675998 for "An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)" at ClinicalTrials.gov; Clinical trial number NCT03427125 for "A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis" at ClinicalTrials.gov
Laboratory evaluation reveal normal serum calcium levels and hyperphosphatemia. Rarely ALP (alkaline phosphatase – an enzyme active at sites of bone formation) may be elevated. Treatment is normalization of serum phosphate levels and resection of lesions. Surgical removal should be complete and if part of it is left, recurrence is likely to ...
Ad
related to: hyperphosphatemia when to treat a patient